How many morphine 15mg would equal one dillaudid 4mg?

Answer 1

It would take just over 2, Morphine to Hydromorphone ration of conversion i 10:1.

Every 10mg of Morphine is like 1mg of Diluadid and ever 10mg of Morphine is like taking 5mg of Oxycodone or DiaMorphine (Hreoin).

Answer 2

You Can Purchase Morphine 10mg Online without RX With Overnight Guaranteed Delivery So Order Here - Genericambienonline. com

Special Risk Patients

DILAUDID ORAL LIQUID and DILAUDID TABLETS should be given with caution and the

initial dose should be reduced in the elderly or debilitated and those with severe

impairment of hepatic, pulmonary or renal functions; myxedema or hypothyroidism;

adrenocortical insufficiency (e.g., Addison's Disease); CNS depression or coma; toxic

psychoses; prostatic hypertrophy or urethral stricture; gall bladder disease; acute

Alcoholism; delirium tremens; kyphoscoliosis or following gastrointestinal surgery.

The administration of opioid analgesics including DILAUDID ORAL LIQUID and DILAUDID

TABLETS may obscure the diagnoses or clinical course in patients with acute abdominal

conditions and may aggravate preexisting convulsions in patients with convulsive

disorders.

Reports of mild to severe seizures and myoclonus have been reported in severely

compromised patients, administered high doses of parenteral hydromorphone, for cancer

and severe pain. Opioid administration at very high doses is associated with seizures and

myoclonus in a variety of diseases where pain control is the primary focus.

Use in Drug and Alcohol Dependent Patients

DILAUDID should be used with caution in patients with alcoholism and other drug

dependencies due to the increased frequency of opioid tolerance, dependence, and the

risk of addiction observed in these patient populations. Abuse of DILAUDID in combination

with other CNS depressant drugs can result in serious risk to the patient.

Hydromorphone is an opioid with no approved use in the management of addictive

disorders.

Use in Ambulatory Patients

DILAUDID ORAL LIQUID and DILAUDID TABLETS may impair mental and/or physical

ability required for the performance of potentially hazardous tasks (e.g. driving, operating

machinery). Patients should be cautioned accordingly. DILAUDID may produce orthostatic

hypotension in ambulatory patients.

Use in Biliary Tract Disease

Opioid analgesics, including DILAUDID ORAL LIQUID and DILAUDID TABLETS, should

also be used with caution in patients about to undergo surgery of the biliary tract since it

may cause spasm of the sphincter of Oddi.

Tolerance and Physical Dependence

Tolerance is the need for increasing doses of opioids to maintain a defined effect such as

analgesia (in the absence of disease progression or other external factors). Physical

dependence is manifested by withdrawal symptoms after abrupt discontinuation of a drug

or upon administration of an antagonist. Physical dependence and tolerance are not

unusual during chronic opioid therapy.

The opioid abstinence or withdrawal syndrome is characterized by some or all of the

following: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia,

mydriasis. Other symptoms also may develop, including: irritability, anxiety, backache,

joint pain, weakness, abdominal cramps, insomnia, nausea, anorexia, vomiting, diarrhea,

or increased blood pressure, respiratory rate, or heart rate.

In general, opioids used regularly should not be abruptly discontinued.

Information for Patients/Caregivers

Patients receiving DILAUDID (hydromorphone hydrochloride) ORAL LIQUID or DILAUDID

TABLETS or their caregivers should be given the following information by the physician,

nurse, or pharmacist:

Patients should be aware that DILAUDID tablets contain hydromorphone, which is

a morphine-like substance and which could cause severe adverse effects including

respiratory depression and even death if not taken according to the prescriber’s

directions.

Patients should be advised to report pain and adverse experiences occurring

during therapy. Individualization of dosage is essential to make optimal use of this

medication.

Patients should be advised not to adjust the dose of DILAUDID without consulting

the prescribing professional.

Patients should be advised that DILAUDID may impair mental and/or physical

ability required for the performance of potentially hazardous tasks (e.g., driving,

operating heavy machinery).

Patients should not combine DILAUDID with alcohol or other central nervous

system depressants (sleep aids, tranquilizers) except by the orders of the

prescribing physician, because dangerous additive effects may occur, resulting in

serious injury or death.

Women of childbearing potential who become, or are planning to become pregnant

should be advised to consult their physician regarding the effects of analgesics and

other drug use during pregnancy on themselves and their unborn child.

Patients should be advised that DILAUDID is a potential drug of abuse. They

should protect it from theft, and it should never be given to anyone other than the

individual for whom it was prescribed.

Patients should be advised that if they have been receiving treatment with